Drugs in obstetric & gynecology Department of obstetrics

Slides:



Advertisements
Similar presentations
DRUGS AFFECTING UTERINE MUSCLE CONTRACTILITY
Advertisements

Lecturer of anesthesia & intensive care Faculty of medicine Ain Shams University 2012.
Hypertensive Disorder in Pregnancy
Electrolyte and Metabolic Disturbances AHMED GHALI MD.
1-DRUGS AFFECTING UTERINE MUSCLE CONTRACTILITY
DRUGS AFFECTING UTERINE MOTILITY
Postpatrum Hemorrhage and Third Stage Emergencies
Care of the pregnant woman Year 2 Lent term. The Case 38 year old booked at 12 weeks gestation in the antenatal clinic Expecting her third baby 1 st baby.
Epilepsy 2 Dr. Hawar A. Mykhan.
Coronary vasodilators Antianginal drugs  Angina pectoris: is a clinical syndrome characterized by paroxysm of pain in the anterior chest caused by insufficient.
Obstetric Pharmacology. Magnesium Sulfate n Actions Not clearly understood Seems to decrease release of acetylcholine at neuromuscular junction Depresses.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 11: The Critically Ill Pregnant Woman.
Magnesium sulphate in the Management of Eclampsia in Malawi Dr. Chisale Mhango FRCOG 1 NPC Training in MNH.
OXYTOCIN It is an octapeptide synthesized in hypothalamus and stored in pituitory. Trade name:  Pitocin, Syntocinon(1 amp= 1 ml= 5 IU)
Drugs That Affect Uterine Function
OXYTOCIN Dr.Dhanalakshmy DNB (O&G).
Agents Used in Obstetrical Care
Drugs for Hypertension
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
Pre-eclampsia/Eclampsia. Pre-eclampsia: hypertension >140/90, proteinuria >0.3g/L Eclampsia: seizures Incidence: – Pre-eclampsia: 2-10% of all pregnancies.
Preterm labor.
Complication during pregnancy and its nursing management: - Pregnancy induces hypertension. Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture.
Management of severe hypertension.  For women with persistent chronic hypertension with SBP >160 or DBP >105, start antihypertensive therapy  Maintain.
PHYSIOLOGICAL CHANGES IN PREGNANCY 1.Blood vol.  50% 2. Plasma vol.  disprop. to red cell mass 3. HCT  DEFINITION: Hb < 12-g/dl in non pregnant In.
Preterm Labor 早 产 林建华. epidemiology Labor and delivery between 28 – weeks Labor and delivery between 28 – weeks 5%-10% 5%-10% be the leading.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and.
Preterm Labor Williams CH.36. Preterm Birth Death, severe neonatal morbidities Common before 26 weeks Universal before 24 weeks.
Case I A 47 old male presents to your office for a yearly checkup. He smokes 40 cigarette/day, and examination detect wheezy chest and bronchospasm. His.
MANAGEMENT OF PRETERM LABOR WITH INTACT MEMBRANES by Dr. Elmizadeh.
Postpartum Hemorrhage
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
Chapter 22 Agents Used to Treat Anemias. Anemia p526 Decrease in hemoglobin or decrease in RBCs Many causes of anemia – Iron deficiency anemia – Chemotherapy.
Drugs acting on the uterus
Specific Objectives: At the end of the session, the participants must be able to 1. Demonstrate the proper conduct of referrals 2. Recognize referral.
TREATMENT IRON DEFICIENCY ANEMIA. 3 Approaches in the Treatment of IDA: 1.Red Cell Transfusion 2.Oral Iron Therapy 3.Parenteral Iron Therapy Braunwald.
In clinical practice the following drugs are of importance: 1- OXYTOCINE. 2- ERGOMETRINE. 3- PROSTAGLANDINS.
DRUGS USED IN UTERINE MOTILITY
 Prazosin, doxazosin, and terazosin  They causing relaxation of both arterial and venous smooth muscle. Postural hypotension may occur in some individuals.
DRUGS AFFECTING UTERINE MUSCLE CONTRACTILITY. Objectives At the end of the lectures, students should be able to know and understand the: 1.Drugs used.
General Anesthesia in Equine Emergencies.
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
Clinical features Abnormal vasculogenesis and angiogenesis and releasing of anti-angiogenic factors results in Vasospasm Endothelial dysfunction Etiology.
OBSTETRICAL DRUG REVIEW
HTN Complications of Pregnancy
Anaesthetic Management Of Cardiac Patients
Multisystem.
Pre-eclampsia Matthew Beaumont.
Chronic Hypertension Monitoring
Drugs for Hypertension
Induction of Parturition
Eclampsia -a neurological condition associated with pre-eclampsia, manifesting with tonic-clonic convulsions in pregnancy that cannot be afributed to.
Drugs acting on the uterus
By: Tamer Abdeldayem Lecturer of gynecology, Alexandria university.
WHO recommendations on interventions to improve preterm birth outcomes
ประธานราชวิทยาลัยสูตินรีแพทย์แห่งประเทศไทย
postpartum complication
Obstetric Pharmacology
Placental abruption (accidental hemorrhage
Eclampsia -a neurological condition associated with pre-eclampsia, manifesting with tonic-clonic convulsions in pregnancy that cannot be afributed to.
Anti hypertensive Drugs
Uterotonic drugs during caesarean section
Eclampsia -a neurological condition associated with pre-eclampsia, manifesting with tonic-clonic convulsions in pregnancy that cannot be afributed to.
Antiarrhythmic Drugs Types of Cardiac Arrhythmias:
Hypertension in Pregnancy
Internal Medicine Workshop Series Laos September /October 2009
Medication Dose/Route Rate Considerations
Oxytocin.
Non opioids pain management
Chapter 4 Sophie Bloom: Preeclampsia
Presentation transcript:

Drugs in obstetric & gynecology Department of obstetrics College of medicine Department of obstetrics Al Mustansiriyah university

oxytocin The word oxytocin was derived from Greek meaning "quick birth" Oxytocin is a peptide of nine amino acids (a nonapeptide Strong rhythmical contraction of myometrium Large doses- sustained contraction(↓ placental blood flow & fetal hypoxia/death) Clinical use: 1- IOL (IV infusion 3U syntocinon+50 ml of saline) 2- Augment slow labour (IV infusion same as above) 3-3rd stage of labour- 5 U IM for HTN ,cardiac disease - IV infusion 40 U in 500ml saline ( PPH) 4-Surgical termination of preg./ERPC- 5U slow IV

Oxytocin 10 IU/1ml/amp, in 500ml N/S, 20 mU/ml Moad of action :Uterine stimulant, by increasing intracellular concentrations of calcium in uterine myometrial tissue OXYTOCIN also has pressor and antidiuretic activity which may be exhibited with high doses Antidiuresis appears to be initiated by the direct action of oxytocin on the kidney. The action of the drug stimulates renal tubular absorption of free water.

SE: Cardiovascular: - The cardiovascular effects of oxytocin used postpartum consist of HYPOTENSION followed by a period of HYPERTENSION - arrhythmias - peripheral arteriospasm - myocardial infarction: coronary artery spasm(?) maybe related to supine hypotension, epidural anesthesia, ephedrine, cigarette smoking, intravenous oxytocin

Others: Nausea and vomiting, uterine hypertonia or rupture uterus, flushing

Ergometrine 0.2mg/1ml/amp : is an ergot derivative with direct uterine and vascular smooth muscle contractile properties Dose :give IV only in emergency because of potential for HTN & CVA. Give over >1 min & monitor BP. Side effects: hypertension, thrombophlebitis, leg cramps, ruptured uterus. – Nausea, vomiting, abdominal pain, chest pain, palpitation, Stroke & MI

Clinical use: 1- Management of 3rd stage of labour 0.2 milligram after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium, which may be repeated every 2 to 4 hours as needed This drug should not be routinely administered intravenously because of the possibility of inducing sudden hypertensive and cerebrovascular accidents

If intravenous administration is considered essential as a life-saving measure, Methergine should be given slowly over a period of no less than 60 seconds, with careful monitoring of blood pressure 2 - Management of PPH - 2nd dose give. Alternatively IV ergometrine can be given (works with in 40 sec)

Contraindications: hypertension and cardiac disease. It is usually combined with oxytocin as syntometrine. Syntometrine IM: 5U syntocinon(rhythmic contraction in 2min) + 500µg ergometrine(sustained contraction in 7 min)

Dinoprostone ( prostin E2) Vaginal pessary/gel Clinical use: IOL – 3mg 6hrs apart ( no more than 2 pessaries in 24hrs and max. 3 doses) Side effect: Nausea ,vomiting, diarrhoea, fever, Uterine hyperstimulation , HTN, bronchospasm Advantages : - Mobile patient -Reduce need for syntocinon

Carboprost ( Hemabate) Dose ; 250µg deep IM repeated every 15 min max 8 doses. (OR Intra-myometrial use at C/S) Side effects: Nausea ,vomiting, diarrhoea, fever, bronchospasm, dyspnoea, pulmonary oedema, HTN, cardiovascular collapse Clinical use: Postpartum haemorrhage

Antihypertension Methyldopa It is a centrally acting α2-adrenergic agonist Dose: The usual starting dosage of Methyldopa tablet is 250 mg two or three times a day in the first 48 hours then the Maintenance dose is 500 mg to 2 g in two to four doses. Indications: gestational hypertension (or pregnancy induced hypertension) and pre-eclampsia. Side effects : it is relatively safe in pregnancy compared to many other antihypertensive which may affect the fetus , however it is produce a number of side effect include: SE :Headache,dizziness,dry mouth , postural hypotension,nightmares, mild psychosis, depression,hepatitis & jaundice

Important to stop drug in postnatal period Labetolol 100-200mg BD/TDS PO max 2.4g/24hr ACE inhibitors are contraindicated in pregnancy

hydralazine It is a direct-acting smooth muscle relaxant. Dose: Dilute hydralazine 1 mL(20 mg) with normal saline, the initial dose is 5-10 mg as ordered given by slow intravenous injection over 2 minutes. Blood pressure is taken at 5 minute intervals for at least 20 minutes following each bolus. After 15 minutes, depending upon response, a second dose of 5 mg may be given. Note that the maximal effect occurs 15-20 minutes after each bolus if still no benefit give maintenance dose. Indications: Intravenous hydralazine is used for the acute control of blood pressure in pre-eclampsia and eclampsia. Side effects: Facial flushing and headache, tachycardia, nausea, vomiting, dizziness, anxiety and tremor.

steroid Use between 32-34 weeks arguable- may no benefit RDS but may benefit IVH up to 34 weeks Regimens: -Betamethasone 12 mg IM, 2 doses, q 24 hr -Dexamethasone 6 mg IM, 4 doses, q 12 hr

Maternal Adverse Effects Short term: glucose control, pulmonary edema, infection Long term: no adverse effects Fetal Adverse Effects No long term effects of single course Multiple course associated w/ infection, abnormal development

Tocolytic drug Beta-mimetics Function: Stimulate beta2 receptors in uterus and lung, decrease contractility Salbutamol inhaler- 100 mcg x 2 puffs stat Terbutaline- 250 mcg subcutaneous Clinical use: both drugs are used for short term. (i) relaxing uterus at C/S (ii) ECV procedure

Tremor, nervousness, N/V, anxiety, SOB, palpitations, chest pain Side effect: Tremor, nervousness, N/V, anxiety, SOB, palpitations, chest pain Hyperglycemia, electrolyte abnormalities Fluid retention, Hypotension, pulmonary oedema Headache, tachycardia, MI ,arrhythmias, hypotension & collapse

Contra indications Absolute: Maternal cardiac disease, eclampsia, severe pre-eclampsia, hemorrhage, uncontrolled hyperthyroid, diabetes Relative: Diabetes, hypertension, migraines, sepsis

nifidipin Calcium Channel blocker Clinical use: Mild to moderate hypertension- 5-20 mg TDS/PO Severe HTN- 10 mg Retard/PO Tocolytic- Incremental doses every 20 min until contraction stop, then 20 mg TDS/PO Side effects: Headache,dizziness,palpitation, tachycardia, hypotension,sweating & syncope.

Magnesium sulphate Clinical use: Prevention & treatment of seizure in eclampsia / severe pre eclampsia Dose: 4g IV stat then 1g/hr to be continued 24hr after last seizure Side effects: nausea,vomiting,flushing, drowsiness,confusion,loss of tendon reflexes, hypotension, decrease U/O, respiratory depression, arrhythmias,cardiac arrest Because of toxicity, Mg levels monitored

Crosses placenta, no adverse fetal effects (may have less reactivity) Magnesium sulphate Crosses placenta, no adverse fetal effects (may have less reactivity) Contraindications: Myasthenia Gravis, renal failure, hypocalcemia Exam: Fluid I/O, UOP, VS, mental status hourly Pulm exam Reflexes (loss when level >8) Therapeutic level: 5.5-7.5 mg/dl, toxic >15 Antidote: calcium gluconate

Oral Iron Parenteral Ferrous Sulfate (Feosol) – 300 mg tid Side Effects are extremely mild: Nausea, upper abdominal pain, constipation or diarrhea. Cheapest form of Iron and one of the most widely used Parenteral Iron Dextran (Imferon) – IM or IV Indicated for patients who cannot tolerate or absorb oral iron or where oral iron is insufficient to treat the condition ie. Malabsorption syndrome, prolonged salicylate therapy, dialysis patients

Folic acid Source in food – yeast, egg yolk, liver and leafy vegetables Folic Acid (F.A.) is absorbed in the small intestines. F.A. is converted to tetrahydrofolate by dihydrofolate reductase. Folic Acid deficiency (F.A. Deficiency) is also called Will’s Disease. Deficiency may produce megaloblastic anemia; neural tube defect in fetus. Used for treatment of megaloblastic anemia due to folic acid deffecinecy,used to prevent neural tube defect. Given preconception and throughout the pregnancy   

Folic acid Folic acid is a vitamin B Dose: as prophylactic 0.4 mg one tablet per day as therapeutic 5mg one tablet per day Indications: as prophylactic start taking folic acid tablets before becoming pregnant and Continue to take folic acid tablets for the first 12 weeks of pregnancy. as therapeutic indicated in: 1-previously affected pregnancy. 2- mother has family history of spinal cord defect 3-mother takes medication for epilepsy. 4-obese women- especially if the Body Mass Index (BMI) is 30 or more 5-women have celiac disease, diabetes, sickle cell anemia, or thalassaemia.

Anti-D (Rho) Immunoglobulin available as 250, 500 and 2500 IU vials, for intramuscular use only Indications Miscarriage, ectopic pregnancy or termination of pregnancy

250 IU anti-D Ig is given up to 19+6 weeks of gestation and 500 IU thereafter. A test for the size of feto-maternal haemorrhage (FMH) should be performed when anti-D Ig is given at or after 20+0 weeks of gestation: Anti-D Ig is not required for spontaneous miscarriage before 12+0 weeks of gestation, unless there is instrumentation or medical evacuation of the uterus. It should be considered in women if there is heavy, repeated bleeding with abdominal pain as she approaches 12+0 weeks of gestation.

Anti-D Ig is not required for spontaneous miscarriage before 12+0 weeks of gestation, unless there is instrumentation or medical evacuation of the uterus. It should be considered in women if there is heavy, repeated bleeding with abdominal pain as she approaches 12+0 weeks of gestation.